1. Management of Drug-Induced Movement Disorders: Focus on Tardive Dyskinesia

3. Drug-Induced Movement Disorders

4. Appropriate Use of Antipsychotic Agents

5. EPS

6. Acute Dystonia

7. Acute Akathisia

8. Drug-Induced Parkinsonism

9. Neuroleptic Malignant Syndrome

10. Tardive Syndromes

11. Movement Disorders in Untreated Patients With Schizophrenia

12. TD

13. Differential Diagnosis

14. Epidemiology of TD

15. Risk Factors for TD

16. Monitoring Movement Disorders in Patients Taking Antipsychotics

17. Rating Scales

18. Schooler-Kane Research Criteria for TD Diagnosis

19. Treatment of TD

20. Other Treatments Used

21. Agents in Development

22. Deutetrabenazine vs Placebo

23. Deutetrabenazine AEs

24. Valbenazine vs Placebo

25. Valbenazine AEs

26. Conclusions

27. Abbreviations